Intelligent adjustment nasal spray type self-control analgesia pump device based on pain tolerance assessment
By integrating the pain tolerance detection mechanism and the dosage adjustment mechanism in the nasal spray automatic analgesic pump device, intelligent drug delivery is achieved according to the patient's pain tolerance, solving the problem that existing devices cannot be suitable for nasal sprays and low intelligence, and improving the automation and accuracy of the device.
Patent Information
- Application Number
- CN202510635138.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-16
- Publication Date
- 2025-08-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing self-controlled analgesic pump device cannot be used for nasal sprays, and cannot intelligently adjust according to the patient's pain tolerance, resulting in poor generalization and low intelligence, making it difficult to meet the actual use needs.
An intelligently adjusted nasal spray-type automatic analgesic pump device based on pain tolerance assessment was designed. The patient's physiological data was collected through a pain tolerance detection mechanism, and pain tolerance was detected using a heart rate sensor, a blood pressure sensor and a skin electrical induction sensor, and the dosage was adjusted through the processor. The dosage and infusion volume were controlled by a servo motor and an electric cylinder to achieve an automated and intelligent dosage process.
It improves the automation and intelligence of the device, can accurately adjust the dosage according to the patient's pain tolerance, meet the use needs of special patients, and improves the convenience and safety of use.
Smart Images

Figure CN120514972A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to an intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment. Background Art
[0002] Analgesia pumps are medical devices that relieve pain through a medication route more tailored to the patient. Currently, analgesia pumps are used intravenously or epidurally for analgesia. Currently, there are no patient-controlled analgesia devices for nasal sprays. Therefore, developing a patient-controlled analgesia device that can be used with a nasal spray bottle would better address the current medication regimen issues faced by patients.
[0003] When using the existing self-controlled analgesia pump device, the patient mainly controls the medication according to his or her own pain sensation to relieve pain. The overall operation is relatively convenient, and it can quickly and timely relieve the patient's pain, and has high use value.
[0004] However, existing intelligently regulated nasal spray self-controlled analgesia pump devices based on pain tolerance assessment have the following shortcomings:
[0005] Existing automatic analgesia pump devices are not suitable for nasal sprays, which results in poor versatility and inability to make timely autonomous adjustments based on the patient's pain tolerance. They have a low level of intelligence and are difficult to meet actual usage needs.
[0006] Therefore, we proposed an intelligent adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment to solve the above problems. Summary of the Invention
[0007] The purpose of the present invention is to provide an intelligently adjustable nasal spray self-controlled analgesic pump device based on pain tolerance assessment. By setting up a pain tolerance detection mechanism, the physiological data of the patient during use is detected and collected, and then the patient's pain tolerance is assessed. The dosage of the drug is adjusted autonomously according to the data, thereby improving the automation and intelligence of the device to solve the problems raised by the above-mentioned background technology.
[0008] To achieve the above-mentioned purpose, the present invention provides the following technical solution: an intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment, comprising an analgesia pump body,
[0009] The installation compartment is fixedly installed at the bottom of the analgesic pump body;
[0010] An infusion mechanism is arranged inside the installation chamber;
[0011] The dosage adjustment mechanism is arranged inside the analgesic pump body;
[0012] A processor is disposed inside the analgesic pump body;
[0013] A power supply module is provided inside the analgesic pump body;
[0014] The pain tolerance detection mechanism is arranged inside the analgesic pump body;
[0015] The pain tolerance detection mechanism includes an integrated module, a connecting wire and a detection module. The integrated module is installed inside the analgesic pump body. The integrated module is connected to the power supply module and the pain tolerance detection mechanism through internal wires. One end of the connecting wire is connected to the integrated module. One end of the connecting wire passes through the analgesic pump body and is connected to the detection module. A heart rate sensor is installed on one side of the detection module, a blood pressure sensor is installed on one side of the detection module, and a skin galvanic induction sensor is installed on one side of the detection module. The heart rate sensor, blood pressure sensor and skin galvanic induction sensor are attached to the user's wrist or arm to collect the user's physiological data and transmit the data to the processor connected to the integrated module via the connecting wire, thereby achieving the purpose of detecting the user's pain tolerance.
[0016] Preferably, the dosage adjustment mechanism includes two fixed plates, both of which are installed inside the analgesic pump body, a connecting shaft is provided between the two fixed plates, a plurality of cams are installed on the outside of the connecting shaft, a servo motor is installed on one side of a single fixed plate, the output end of the servo motor moves through the single fixed plate and is connected to the connecting shaft, two fixed rods are fixedly installed on the bottom of each fixed plate, a first spring is sleeved on the outside of each fixed rod, a sliding plate is slidably installed on the outside of the four fixed rods, a protrusion is installed on the top of the sliding plate, and a plurality of pressure blocks are installed on the bottom of the sliding plate.
[0017] Preferably, the pain tolerance detection mechanism includes two elastic bands, one end of each of the two elastic bands is connected to the detection module, and the other ends of the two elastic bands are plugged together through a buckle.
[0018] Preferably, the infusion mechanism includes a nasal spray bottle, which is arranged inside the mounting chamber, and the top of the nasal spray bottle is connected to a connecting end, one end of the connecting end passes through the mounting chamber and the analgesic pump body and is connected to an infusion hose, one end of the infusion hose passes through the analgesic pump body and is connected to an atomizing nozzle, an opening mechanism is provided on the top of the nasal spray bottle, and an elastic clamping mechanism is provided on the outside of the nasal spray bottle.
[0019] Preferably, the opening mechanism includes a mounting frame, which is installed on the inner side of the analgesic pump body. A servo electric cylinder is installed on the top of the mounting frame. The output end of the servo electric cylinder moves through the mounting frame and is connected to a starting pressure frame. One end of the starting pressure frame moves through the analgesic pump body and the mounting chamber and is arranged above the nasal spray bottle.
[0020] Preferably, the elastic clamping mechanism includes three first limit frames, the three first limit frames are all installed on one side of the interior of the installation bin, the three first limit frames are all attached to the outside of the nasal spray bottle, two telescopic rods are installed on the other side of the interior of the installation bin, a second spring is sleeved on the outside of each telescopic rod, one end of the two telescopic rods is connected to an end plate, three second limit frames are installed on one side of the end plate, and a pull ring is installed on the top of the other side of the end plate.
[0021] Preferably, two hinges are installed at the bottom of the installation bin, and acrylic covers are installed at one end of the two hinges.
[0022] Preferably, a manual flow regulator is installed on one side of the analgesic pump body, and the infusion hose is arranged on the inner side of the manual flow regulator.
[0023] Preferably, a replacement mechanism is inserted into the inner side of the analgesic pump body;
[0024] The replacement mechanism includes a sliding bracket, which is inserted into the interior of the analgesic pump body. Two clamping brackets are installed on the top of the sliding bracket. The infusion hose is clamped inside the two clamping brackets. The connecting end is arranged inside one end of the sliding bracket. One end of the sliding bracket is connected to an end plate, and a pull ring is installed on one side of the end plate.
[0025] Preferably, a display screen is provided on the surface of the analgesic pump body, and a plurality of control buttons are provided on the surface of the analgesic pump body.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] 1. The present invention sets a pain tolerance detection mechanism to detect and collect the patient's physiological data when using the device, and then evaluate the patient's pain tolerance. The drug dosage is autonomously adjusted according to the data, thereby improving the automation and intelligence of the device and meeting actual usage needs.
[0028] 2. The present invention provides a dosage adjustment mechanism to squeeze the infusion pipeline to adjust the dosage. The overall accuracy is high and can meet the needs of special patients. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 This is a stereoscopic diagram of the main structure of the intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment of the present invention;
[0030] Figure 2 A side view of the structure of the intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment of the present invention;
[0031] Figure 3 A three-dimensional diagram of the internal structure of the intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment of the present invention;
[0032] Figure 4 This is an enlarged stereoscopic view of the pain tolerance detection mechanism in the intelligently adjustable nasal spray automatic analgesia pump device based on pain tolerance assessment of the present invention;
[0033] Figure 5 This is an enlarged stereoscopic view of the dosage adjustment mechanism of the intelligently adjustable nasal spray automatic analgesia pump device based on pain tolerance assessment of the present invention;
[0034] Figure 6 This is an enlarged stereoscopic view of the elastic clamping mechanism in the intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment of the present invention;
[0035] Figure 7 This is an enlarged stereoscopic view of the infusion mechanism of the intelligently adjustable nasal spray automatic analgesia pump device based on pain tolerance assessment of the present invention;
[0036] Figure 8 This is an enlarged stereoscopic view of the opening mechanism of the intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment of the present invention;
[0037] Figure 9 This is an enlarged stereoscopic view of the replacement mechanism in the intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment of the present invention.
[0038] Figure: 1, analgesic pump body; 2, mounting chamber; 3, infusion mechanism; 301, nasal spray bottle; 302, connecting end; 303, infusion hose; 304, atomizing nozzle; 4, opening mechanism; 401, mounting frame; 402, servo electric cylinder; 403, starting pressure frame; 5, dosage adjustment mechanism; 501, fixing plate; 502, connecting shaft; 503, servo motor; 504, cam; 505, fixing rod; 506, first spring; 507, sliding plate; 508, bump; 509, pressure block; 6, processor; 7, power supply module; 8, pain tolerance detection mechanism; 801, collection module; 802, connecting wires; 803, detection module; 804, heart rate sensor; 805, blood pressure sensor; 806, skin galvanic induction sensor; 807, elastic band; 9, elastic clamping mechanism; 901, first limit frame; 902, telescopic rod; 903, second spring; 904, end plate; 905, second limit frame; 906, pull ring; 10, hinge; 11, acrylic cover; 12, manual flow regulator; 13, replacement mechanism; 1301, sliding bracket; 1302, clamping bracket; 1303, end plate; 1304, pull ring; 14, display screen; 15, control button. DETAILED DESCRIPTION
[0039] The following will be combined with the accompanying drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the implementation regulations described are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making any creative efforts are within the scope of protection of the present invention.
[0040] Please see the attached Figure 1 -Attached Figure 9 As shown, the present invention provides a technical solution: an intelligent adjustable nasal spray automatic analgesia pump device based on pain tolerance assessment, comprising an analgesia pump body 1,
[0041] The installation compartment 2 is fixedly installed at the bottom of the analgesic pump body 1;
[0042] The infusion mechanism 3 is arranged inside the installation chamber 2;
[0043] The dosage adjustment mechanism 5 is arranged inside the analgesic pump body 1;
[0044] The processor 6 is arranged inside the analgesic pump body 1;
[0045] The power supply module 7 is arranged inside the analgesic pump body 1;
[0046] The pain tolerance detection mechanism 8 is arranged inside the analgesic pump body 1;
[0047] The pain tolerance detection mechanism 8 includes an integrated module 801, a connecting wire 802 and a detection module 803. The integrated module 801 is installed inside the analgesic pump body 1. The integrated module 801 is connected to the power supply module 7 and the pain tolerance detection mechanism 8 through an internal wire. One end of the connecting wire 802 is connected to the integrated module 801. One end of the connecting wire 802 passes through the analgesic pump body 1 and is connected to the detection module 803. A heart rate sensor 804 is installed on one side of the detection module 803. A blood pressure sensor 805 is installed on one side of the detection module 803. A skin galvanic induction sensor 806 is installed on one side of the detection module 803. The heart rate sensor 804, the blood pressure sensor 805 and the skin galvanic induction sensor 806 are attached to the user's wrist or arm to collect the user's physiological data and transmit the data The data is transmitted to the processor 6 connected to the integrated module 801 via the connecting wire 802, thereby achieving the purpose of detecting the user's pain tolerance. Through the setting of the pain tolerance detection mechanism 8, the physiological data of the patient when using the device is detected and collected, and the patient's pain tolerance is evaluated. The drug dosage is adjusted autonomously according to the data, and the automation and intelligence level of the device are improved to meet actual use needs. Among them, the processor 6, the power supply module 7 and the pain tolerance detection mechanism 8 are connected by internal wires, and the processor 6 is respectively connected to the drug dosage adjustment mechanism 5 and the driving device in the opening mechanism 4 by internal wires. At the same time, the processor 6 is also connected to the display module integrated with the display screen 14 by internal wires. The data processed and analyzed by the processor 6 will be displayed on the display screen 14.
[0048] according to Figure 3 and Figure 5 As shown, the dosage adjustment mechanism 5 includes two fixed plates 501, both of which are installed inside the analgesic pump body 1, a connecting shaft 502 is arranged between the two fixed plates 501, and multiple cams 504 are installed on the outside of the connecting shaft 502, a servo motor 503 is installed on one side of a single fixed plate 501, and the output end of the servo motor 503 is movable through the single fixed plate 501 and connected to the connecting shaft 502, two fixed rods 505 are fixedly installed at the bottom of each fixed plate 501, and a first spring 506 is sleeved on the outside of each fixed rod 505, and a sliding plate 507 is slidably installed on the outside of the four fixed rods 505, a protrusion 508 is installed on the top of the sliding plate 507, and multiple pressing blocks 509 are installed on the bottom of the sliding plate 507. Through the setting of the dosage adjustment mechanism 5, the infusion pipeline is squeezed to adjust the dosage, and the overall precision is high, which can meet the use needs of special patients.
[0049] according to Figure 2 、 Figure 3 and Figure 4As shown, the pain tolerance detection mechanism 8 includes two elastic bands 807, one end of the two elastic bands 807 are connected to the detection module 803, and the other ends of the two elastic bands 807 are plugged together through buckles. Through the arrangement of the remaining components of the pain tolerance detection mechanism 8, the device can be worn and fixed on the patient's wrist or arm with better stability.
[0050] according to Figure 3 、 Figure 6 and Figure 7 As shown, the infusion mechanism 3 includes a nasal spray bottle 301, which is arranged inside the installation compartment 2, and the top of the nasal spray bottle 301 is connected to a connecting terminal 302, one end of the connecting terminal 302 passes through the installation compartment 2 and the analgesic pump body 1 and is connected to an infusion hose 303, one end of the infusion hose 303 passes through the analgesic pump body 1 and is connected to an atomizing nozzle 304, and the top of the nasal spray bottle 301 is provided with an opening mechanism 4, and the outside of the nasal spray bottle 301 is provided with an elastic clamping mechanism 9. Through the setting of the infusion mechanism 3, rapid delivery of nasal spray can be achieved, and the nasal spray bottle can be quickly replaced, which reduces the overall difficulty of use.
[0051] according to Figure 3 and Figure 8 As shown, the opening mechanism 4 includes a mounting frame 401, which is installed on one side of the interior of the analgesic pump body 1. A servo electric cylinder 402 is installed on the top of the mounting frame 401. The output end of the servo electric cylinder 402 is movable through the mounting frame 401 and is connected to a starting pressure frame 403. One end of the starting pressure frame 403 is movable through the analgesic pump body 1 and the mounting chamber 2 and is arranged above the nasal spray bottle 301. Through the setting of the opening mechanism 4, the infusion mechanism 3 can be quickly started, and the single dosage, number of times and interval time can be controlled. Among them, because the opening mechanism 4 is connected to the processor 6 through an internal wire, when the servo electric cylinder 402 has not been running for a long time, the relevant data is transmitted to the processor 6, and the processor 6 processes and analyzes the data, and displays the data through the display screen 14 to remind the user to use the nasal spray bottle again for subsequent treatment.
[0052] according to Figure 3 and Figure 6As shown, the elastic clamping mechanism 9 includes three first limit frames 901, and the three first limit frames 901 are all installed on one side of the interior of the installation bin 2. The three first limit frames 901 are all fitted on the outside of the nasal spray bottle 301, and two telescopic rods 902 are installed on the other side of the interior of the installation bin 2. The outside of each telescopic rod 902 is sleeved with a second spring 903, and one end of the two telescopic rods 902 is connected to an end plate 904, and three second limit frames 905 are installed on one side of the end plate 904. A pull ring 906 is installed on the top of the other side of the end plate 904. Through the setting of the elastic clamping mechanism 9, the nasal spray bottle can be elastically clamped to prevent it from shaking, improve stability, and is not easy to cause damage to the nasal spray bottle, with higher safety.
[0053] according to Figure 1 and Figure 2 As shown, two hinges 10 are installed at the bottom of the installation chamber 2, and an acrylic cover 11 is installed at one end of the two hinges 10. Through the setting of the hinges 10 and the acrylic cover 11, the internal structure of the installation chamber 2 can be protected, and the nasal spray can be replaced conveniently.
[0054] according to Figure 1 and Figure 3 As shown, a manual flow regulator 12 is installed on one side of the analgesic pump body 1, and the infusion hose 303 is arranged on the inner side of the manual flow regulator 12. Through the setting of the manual flow regulator 12, the infusion volume can be manually adjusted to meet diverse usage requirements.
[0055] according to Figure 1 、 Figure 3 、 Figure 6 and Figure 9 As shown, a replacement mechanism 13 is inserted into the inner side of the analgesic pump body 1;
[0056] The replacement mechanism 13 includes a sliding bracket 1301, which is inserted into the interior of the analgesic pump body 1. Two clamping brackets 1302 are installed on the top of the sliding bracket 1301. The infusion hose 303 is clamped inside the two clamping brackets 1302. The connecting end 302 is set inside one end of the sliding bracket 1301. One end of the sliding bracket 1301 is connected to an end plate 1303, and a pull ring 1304 is installed on one side of the end plate 1303. Through the setting of the replacement mechanism 13, the components in the infusion mechanism 3 can be replaced, thereby meeting the medical and health permit and enabling the device to be used for different patients.
[0057] according to Figure 1 As shown, a display screen 14 is provided on the surface of the analgesic pump body 1, and a plurality of control buttons 15 are provided on the surface of the analgesic pump body 1. Through the setting of the display screen 14 and the control buttons 15, the current operating parameters of the device can be displayed and the operating parameters can be adjusted at the same time.
[0058] Working principle: First, the battery is put into the power supply module 7 to supply energy to the electrical equipment in the device to ensure the normal operation of the device. Then, the heart rate sensor 804, blood pressure sensor 805 and skin electrical induction sensor 806 are worn on the patient's wrist or arm through two elastic bands 807.
[0059] During the data evaluation phase, the heart rate sensor 804, blood pressure sensor 805 and skin electrical induction sensor 806 first detect and collect the patient's physiological data, and transmit the data to the integrated module 801 via the connecting wire 802. The integrated module 801 then transmits the data to the processor 6 for analysis and processing.
[0060] During the nasal spray treatment phase, first, the atomizing nozzle 304 is inserted into the patient's nasal cavity, and then the control button 15 is pressed to start the device. The processor 6 controls the servo electric cylinder 402 to start according to the data. The servo electric cylinder 402 pushes the starting pressure frame 403 downward, causing the nasal spray bottle 301 to be pressurized to spray the nasal spray. The nasal spray is then transported from the infusion hose 303 to the atomizing nozzle 304 for spraying, and the patient is given medication treatment.
[0061] In the automatic adjustment stage, first, the pain tolerance detection mechanism 8 continuously detects and collects the patient's physiological data, and the processor 6 monitors and analyzes the physiological data. If the patient's pain tolerance is high, the processor 6 controls the servo motor 503 to start, and the servo motor 503 drives the connecting shaft 502 to rotate, causing the cam 504 to rotate and squeeze the protrusion 508, so that the sliding plate 507 slides on the fixed rod 505, and squeezes the first spring 506 to shrink it. When the pressure block 509 reaches the top of the infusion hose 303 and applies pressure to it, the dosage is reduced. On the contrary, if the patient's pain tolerance is low, the processor 6 controls the servo electric cylinder 402 to increase the thrust, so that the dosage of the nasal spray bottle 301 is increased.
[0062] During the spray replacement phase, first, the acrylic cover 11 is moved to force the hinge 10 to drive the acrylic cover 11 to rotate and open. Next, the pull ring 906 is pulled to make the end plate 904 pull the telescopic rod 902 and the second spring 903 to contract. At this time, the used nasal spray bottle 301 is removed by screwing. Then, the atomizing nozzle 304 is removed from one end of the infusion hose 303. The pull ring 1304 is pulled to force the sliding bracket 1301 to slide outward, and the infusion hose 303 clamped in the two clamping brackets 1302 is removed from the analgesic pump body. The analgesic pump body 1 is taken out, and the nasal spray bottle 301, the infusion hose 303 and the atomizing nozzle 304 are cleaned and replaced. After the replacement is completed, the replaced infusion hose 303 is clamped in the two clamping frames 1302, and the replacement mechanism 13 is reinserted into the analgesic pump body 1. The replaced nasal spray bottle 301 is screwed and installed at the connecting end 302, and then the pull ring 906 is loosened to make the second spring 903 rebound, and cooperate with the telescopic rod 902 to push the end plate 904 to reset, prompting the second limit frame 905 to clamp the nasal spray bottle 301.
[0063] By following the above-described procedures, you can complete the use of the intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment.
[0064] Although the present invention has been described in detail with reference to the aforementioned embodiments, it is still possible for those skilled in the art to modify the technical solutions described in the aforementioned embodiments, or to make equivalent substitutions for some of the technical features therein. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. An intelligently regulated nasal spray self-controlled analgesia pump device based on pain tolerance assessment, characterized by: Including analgesia pump body (1), An installation chamber (2) is fixedly installed at the bottom of the analgesic pump body (1); An infusion mechanism (3) is arranged inside the installation chamber (2); A dosage adjustment mechanism (5) is provided inside the analgesic pump body (1); A processor (6) is arranged inside the analgesic pump body (1); A power supply module (7) is arranged inside the analgesic pump body (1); A pain tolerance detection mechanism (8) is arranged inside the analgesic pump body (1); The pain tolerance detection mechanism (8) includes an integrated module (801), a connecting wire (802) and a detection module (803). The integrated module (801) is installed inside the analgesic pump body (1). The integrated module (801) is connected to the power supply module (7) and the pain tolerance detection mechanism (8) through an internal wire. One end of the connecting wire (802) is connected to the integrated module (801). One end of the connecting wire (802) passes through the analgesic pump body (1) and is connected to the detection module (803). The detection module (803) A heart rate sensor (804) is installed on one side of the detection module (803), a blood pressure sensor (805) is installed on one side of the detection module (803), and a skin galvanic induction sensor (806) is installed on one side of the detection module (803). The heart rate sensor (804), blood pressure sensor (805) and skin galvanic induction sensor (806) are attached to the wrist or arm of the user to collect the user's physiological data, and the data is transmitted to the processor (6) connected to the integrated module (801) via the connecting wire (802), thereby achieving the purpose of detecting the user's pain tolerance.
2. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 1, characterized in that: The dosage adjustment mechanism (5) includes two fixed plates (501), both of which are installed inside the analgesic pump body (1), a connecting shaft (502) is provided between the two fixed plates (501), a plurality of cams (504) are installed on the outside of the connecting shaft (502), a servo motor (503) is installed on one side of a single fixed plate (501), the output end of the servo motor (503) is movable through the single fixed plate (501) and connected to the connecting shaft (502), two fixed rods (505) are fixedly installed at the bottom of each fixed plate (501), a first spring (506) is sleeved on the outside of each fixed rod (505), a sliding plate (507) is slidably installed on the outside of the four fixed rods (505), a protrusion (508) is installed on the top of the sliding plate (507), and a plurality of pressure blocks (509) are installed at the bottom of the sliding plate (507).
3. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 2, characterized in that: The pain tolerance detection mechanism (8) comprises two elastic bands (807), one end of each of the two elastic bands (807) is connected to the detection module (803), and the other ends of the two elastic bands (807) are plugged together via a buckle.
4. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 3, characterized in that: The infusion mechanism (3) includes a nasal spray bottle (301), which is arranged inside the installation chamber (2). The top of the nasal spray bottle (301) is connected to a connecting terminal (302), one end of the connecting terminal (302) passes through the installation chamber (2) and the analgesic pump body (1) and is connected to an infusion hose (303), one end of the infusion hose (303) passes through the analgesic pump body (1) and is connected to an atomizing nozzle (304), an opening mechanism (4) is provided on the top of the nasal spray bottle (301), and an elastic clamping mechanism (9) is provided on the outside of the nasal spray bottle (301).
5. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 4, characterized in that: The opening mechanism (4) includes a mounting frame (401), the mounting frame (401) is mounted on one side of the interior of the analgesic pump body (1), a servo electric cylinder (402) is mounted on the top of the mounting frame (401), the output end of the servo electric cylinder (402) is movable through the mounting frame (401) and is connected to a starting pressure frame (403), one end of the starting pressure frame (403) is movable through the analgesic pump body (1) and the mounting chamber (2) and is arranged above the nasal spray bottle (301).
6. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 5, characterized in that: The elastic clamping mechanism (9) includes three first limiting frames (901), and the three first limiting frames (901) are all installed on one side of the interior of the installation chamber (2). The three first limiting frames (901) are all attached to the outside of the nasal spray bottle (301). Two telescopic rods (902) are installed on the other side of the interior of the installation chamber (2), and the outside of each telescopic rod (902) is sleeved with a second spring (903). One end of the two telescopic rods (902) is connected to an end plate (904), and three second limiting frames (905) are installed on one side of the end plate (904). A pull ring (906) is installed on the top of the other side of the end plate (904).
7. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 6, characterized in that: Two hinges (10) are installed at the bottom of the installation chamber (2), and one end of the two hinges (10) is installed with an acrylic cover (11).
8. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 7, characterized in that: A manual flow regulator (12) is installed on one side of the analgesic pump body (1), and the infusion hose (303) is arranged on the inner side of the manual flow regulator (12).
9. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 4, characterized in that: A replacement mechanism (13) is inserted into the inner side of the analgesic pump body (1); The replacement mechanism (13) includes a sliding bracket (1301), which is inserted into the interior of the analgesic pump body (1), and two clamping brackets (1302) are installed on the top of the sliding bracket (1301). The infusion hose (303) is clamped inside the two clamping brackets (1302), and the connecting end (302) is arranged inside one end of the sliding bracket (1301). One end of the sliding bracket (1301) is connected to an end plate (1303), and a pull ring (1304) is installed on one side of the end plate (1303).
10. The intelligently adjustable nasal spray self-controlled analgesia pump device based on pain tolerance assessment according to claim 9, characterized in that: The surface of the analgesic pump body (1) is provided with a display screen (14), and the surface of the analgesic pump body (1) is provided with a plurality of control buttons (15).